138 related articles for article (PubMed ID: 11000989)
21. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
22. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
Vellenga E; van Putten WL; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Jonkhoff AR; Huijgens PC; Verdonck LF; van der Lelie J; Schouten HC; Gmür J; Wijermans P; Gratwohl A; Hess U; Fey MF; Löwenberg B
Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916
[TBL] [Abstract][Full Text] [Related]
23. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
[TBL] [Abstract][Full Text] [Related]
24. Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience.
Castagnola C; Alessandrino EP; Lunghi M; Bernasconi P; Della Porta M; Mangiacavalli S; Colombo A; Corso A; Pagnucco G; Lazzarino M; Bernasconi C
Ann Hematol; 2001 May; 80(5):267-71. PubMed ID: 11446728
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia.
Miyamoto T; Nagafuji K; Harada M; Eto T; Fujisaki T; Kubota A; Akashi K; Mizuno S; Takenaka K; Kanaji T
Br J Haematol; 1995 Sep; 91(1):132-8. PubMed ID: 7577620
[TBL] [Abstract][Full Text] [Related]
26. Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome.
Raos M; Nemet D; Bojanić I; Sertić D; Batinić D; Dusak V; Dubravcić K; Mazić S; Serventi-Seiwerth R; Mrsić M; Golubić-Cepulić B; Labar B
Coll Antropol; 2010 Mar; 34(1):105-15. PubMed ID: 20437639
[TBL] [Abstract][Full Text] [Related]
27. Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia.
Reichle A; Rothe G; Krause S; Zaiss M; Ullrich H; Schmitz G; Andreesen R
Leukemia; 1999 Aug; 13(8):1227-34. PubMed ID: 10450751
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of curative effect of autologous peripheral blood stem cell transplantation versus bone marrow transplantation for acute leukemia].
Zhang YZ; Zhang BL; Yao SQ; Liu HC; Lou FD; Gao CJ; Han XP; Wu XX; Zhao Y; Wang QS; Jing Y; Zhang M; Jin HJ; Shi ZJ; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):81-5. PubMed ID: 12667296
[TBL] [Abstract][Full Text] [Related]
29. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
30. Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?
Bruserud O; Foss B; Abrahamsen JF; Gjertsen BT; Ernst P
J Hematother Stem Cell Res; 2000 Aug; 9(4):433-43. PubMed ID: 10982241
[TBL] [Abstract][Full Text] [Related]
31. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Cahn JY; Labopin M; Sierra J; Blaise D; Reiffers J; Ferrant A; Bergmann L; Visani G; Cornelissen J; De Witte T; Bosi A; Frassoni F; Gorin NC
Br J Haematol; 2000 Aug; 110(2):308-14. PubMed ID: 10971386
[TBL] [Abstract][Full Text] [Related]
32. Cryostorage to What End? - Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm Patients.
Kriegsmann K; Pavel P; Bochtler T; Schmitt A; Sauer S; Kriegsmann M; Bruckner T; Klein S; Klüter H; Müller-Tidow C; Wuchter P
Transfus Med Hemother; 2021 Mar; 48(2):91-98. PubMed ID: 33976609
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes.
Wattel E; Solary E; Leleu X; Dreyfus F; Brion A; Jouet JP; Hoang-Ngoc L; Maloisel F; Guerci A; Rochant H; Gratecos N; Casassus P; Janvier M; Brice P; Lepelley P; Fenaux P
Leukemia; 1999 Apr; 13(4):524-9. PubMed ID: 10214857
[TBL] [Abstract][Full Text] [Related]
34. Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia.
Breems DA; Löwenberg B
Br J Haematol; 2005 Sep; 130(6):825-33. PubMed ID: 16156852
[TBL] [Abstract][Full Text] [Related]
35. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device.
Després D; Flohr T; Uppenkamp M; Baldus M; Hoffmann M; Huber C; Derigs HG
J Hematother Stem Cell Res; 2000 Aug; 9(4):557-64. PubMed ID: 10982256
[TBL] [Abstract][Full Text] [Related]
36. Positive selection of autologous peripheral blood stem cells.
Lopez M; Beaujean F
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):71-86. PubMed ID: 11000984
[TBL] [Abstract][Full Text] [Related]
37. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
38. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
Strodtbeck D; Bornhäuser M; Hänel M; Lerche L; Schaich M; Illmer T; Thiede C; Geissler G; Herbst R; Ehninger G; Platzbecker U
Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
[TBL] [Abstract][Full Text] [Related]
39. Autologous peripheral blood progenitor cell transplantation for multiple myeloma.
Attal M; Harousseau JL
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):171-91. PubMed ID: 11000991
[TBL] [Abstract][Full Text] [Related]
40. Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Biol Blood Marrow Transplant; 2017 Apr; 23(4):588-597. PubMed ID: 28089879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
